1,205
Participants
Start Date
June 13, 2019
Primary Completion Date
March 30, 2020
Study Completion Date
March 30, 2020
V114
15-valent pneumococcal conjugate vaccine with serotypes 1, 3, 4, 5, 6A, 6B, 7F, 9V, 14, 18C, 19A, 19F, 22F, 23F, and 33F in each 0.5 mL dose.
Prevnar 13®
13-valent pneumococcal conjugate vaccine with serotypes 1, 3, 4, 5, 6A, 6B, 7F, 9V, 14, 18C, 19A, 19F, and 23F in each 0.5 mL dose.
National Taiwan University Hospital ( Site 0500), Taipei
National Cheng Kung University Hospital ( Site 0501), Dawan
Charlottesville Medical Research Center, LLC ( Site 1003), Charlottesville
Health Research of Hampton Roads, Inc. ( Site 1007), Newport News
Hospital Universitario Quiron Madrid ( Site 0304), Pozuelo de Alarcón
Indago Research & Health Center, Inc ( Site 1002), Hialeah
Lakes Research LLC ( Site 1005), Miami Lakes
Research Centers of America, LLC ( Site 1014), Hollywood
Advanced Medical Research Institute ( Site 0117), Miami
Rapid Medical Research, Inc. ( Site 1011), Cleveland
Alliance for Multispecialty Research, LLC ( Site 1008), Newton
Diagnostics Research Group ( Site 1000), San Antonio
Synexus ( Site 1009), San Antonio
J Lewis Research Inc / Foothill Family Clinic ( Site 1013), Salt Lake City
Synexus ( Site 1001), Mesa
Wake Research Clinical Research Center of Nevada, LLC ( Site 1010), Las Vegas
Artemis Institute for Clinical Research ( Site 1012), San Diego
Colchester Research Group ( Site 2002), Truro
Milestone Research ( Site 2003), London
Bluewater Clinical Research Group Inc ( Site 2004), Sarnia
Manna Research Inc.. ( Site 2007), Toronto
Dynamik Research ( Site 2000), Pointe-Claire
Q & T Research Sherbrooke Inc. ( Site 2001), Sherbrooke
P-One Clinic, Keikokai Medical Corp. ( Site 0400), Hachiōji
Souseikai PS Clinic ( Site 0402), Fukuoka
Souseikai Nishikumamoto Hospital ( Site 0404), Kumamoto
Medical Corporation Heishinkai OPHAC Hospital ( Site 0401), Osaka
Medical Corporation Houeikai Sekino Clinical Pharmacology Clinic ( Site 0403), Tokyo
Instituto de Ciencias Medicas - ICM ( Site 0300), Alicante
CAP Centelles ( Site 0301), Centelles
Merck Sharp & Dohme LLC
INDUSTRY